Back to all products
Product criteria
| TGase Protein Labeling Kits |
| Transglutaminase |
| Reaction stopper |
| Amine-donors |
| Glutamine-donor peptides |
| TGase Labeling Service |
Product criteria
| Substance |
|---|
| Kits 11 |
| Label |
| Biotin 2 |
| Atto-488 1 |
| PEG1,088 2 |
| Atto-532 1 |
| Atto-550 1 |
| Atto-647N 1 |
| Atto-700 1 |
| Dansyl 1 |
| PEG5,000 1 |
| Application |
| Protein labeling 11 |
TGase Protein Labeling Kits
Transglutaminase Labeling Kits are designed to easily obtain mg amounts of labeled proteins.
Transglutaminase enzymatic labeling requires accessible glutamine or lysine residues on your target protein's surface. Therfore in a first step Substrate Finder Kit (L001) characterizes your target protein: it contains accesible glutamine residues or lysine residues or both or it isn’t a substrate at all.
Substrate Finder Kit (L001) will indicate which Labeling Kit is appropriate to modify your target protein with the desired labels: Biotin, PEG1,088, PEG5,000 or ATTO-488TM, ATTO-532TM , ATTO-550TM, ATTO-647NTM, ATTO-700TM,
Please contact us if you are interested in other labels.
Transglutaminase enzymatic labeling requires accessible glutamine or lysine residues on your target protein's surface. Therfore in a first step Substrate Finder Kit (L001) characterizes your target protein: it contains accesible glutamine residues or lysine residues or both or it isn’t a substrate at all.
Substrate Finder Kit (L001) will indicate which Labeling Kit is appropriate to modify your target protein with the desired labels: Biotin, PEG1,088, PEG5,000 or ATTO-488TM, ATTO-532TM , ATTO-550TM, ATTO-647NTM, ATTO-700TM,
Please contact us if you are interested in other labels.
| Art. No. | Name | Unit | Price |
|---|---|---|---|
| L001 | Substrate Finder Kit | 1 Kit | 390 € |
TGase Q-Labeling Kits
TGase K-Labeling Kits
| Art. No. | Name | Unit | Price |
|---|---|---|---|
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit | 550 € |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit | 550 € |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit | 550 € |
Successful ISO9001:2015 recertification 
Dr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease 
Dr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie 
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis 
Transglutaminase antibodies and neurological manifestations of gluten sensitivity 
Design of Oral FXIIIa Blockers as Safer Anticoagulants Mission Impossible? 
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering 
Tridegin as FXIIIa inhibitor 
Microbial transglutaminase: from discovery to market 
Tissue transglutaminase inhibitors 
Tissue transglutaminase in Alzheimers Disease 
Factor XIIIa: novel target for anticoagulation? 
Microbial transglutaminase for site-specific protein conjugation